Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Carole NuechterleinDirector | Aligos TherapeuticsALGS | Open-market buy | 23/10/25 | 23/10/27 | 7,933,601 sh | $0.76 | $6,029,536.76 | +256.6% |